Header cover image

Singaporean (SGX) Pharma Industry Analysis

UpdatedAug 15, 2022
DataAggregated Company Financials
  • 7D0.7%
  • 3M-0.2%
  • 1Y-16.6%
  • YTD-6.9%

The Pharma industry has stayed flat over the last week. As for the longer term, the industry has declined 17% in the last year. As for the next few years, earnings are expected to grow by 3.4% per annum.

Industry Valuation and Performance

Has the Singaporean Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 15 Aug 2022S$4.8bS$1.4bS$253.0m11x19x3.5x
Wed, 13 Jul 2022S$4.9bS$1.3bS$229.0m10.1x21.4x3.7x
Fri, 10 Jun 2022S$4.8bS$1.3bS$229.6m10.6x20.9x3.6x
Sun, 08 May 2022S$4.7bS$1.3bS$228.8m12.5x20.5x3.5x
Tue, 05 Apr 2022S$5.4bS$1.4bS$236.3m11.6x22.7x3.9x
Thu, 03 Mar 2022S$5.5bS$1.4bS$249.5m12.3x21.9x3.9x
Sat, 29 Jan 2022S$5.3bS$1.3bS$212.4m14.1x25.1x4x
Mon, 27 Dec 2021S$5.6bS$1.3bS$212.4m14.4x26.4x4.2x
Wed, 24 Nov 2021S$5.4bS$1.3bS$212.0m14x25.4x4x
Fri, 22 Oct 2021S$5.6bS$1.3bS$204.5m14.1x27.4x4.2x
Sun, 19 Sep 2021S$5.5bS$1.3bS$203.1m14.1x26.9x4.2x
Tue, 17 Aug 2021S$6.0bS$1.3bS$203.2m22.3x29.5x4.6x
Tue, 01 Jun 2021S$5.7bS$1.3bS$205.8m23.3x27.9x4.5x
Fri, 05 Mar 2021S$4.6bS$1.3bS$218.6m16.9x21.2x3.7x
Mon, 07 Dec 2020S$4.1bS$1.3bS$210.7m16.1x19.3x3.2x
Thu, 10 Sep 2020S$4.1bS$1.3bS$239.9m16.1x16.9x3.2x
Wed, 03 Jun 2020S$3.9bS$1.3bS$283.4m12.9x13.7x2.9x
Sat, 07 Mar 2020S$4.0bS$1.4bS$263.1m13.6x15.4x2.9x
Tue, 10 Dec 2019S$4.4bS$1.3bS$265.6m14.7x16.6x3.3x
Mon, 02 Sep 2019S$4.5bS$1.4bS$267.9m14.9x16.8x3.3x
Price to Earnings Ratio


Total Market Cap: S$4.5bTotal Earnings: S$267.9mTotal Revenue: S$1.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Singaporean Pharma Industry Price to Earnings3Y Average 20.8x202020212022
Current Industry PE
  • Investors are relatively neutral on the Singaporean Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 20.8x.
  • The industry is trading close to its 3-year average PS ratio of 3.6x.
Past Earnings Growth
  • Both revenue and earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • This means that sales and the cost of doing business have remained relatively consistent over this period and subsequently, so have profits.

Industry Comparison

How does Singaporean Pharma compare with similar industries?

SG Market-0.39%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
H02 Haw ParS$11.300.8%
T14 Tianjin Pharmaceutical Da Ren Tang GroupUS$1.041.0%
1J5 Hyphens Pharma InternationalS$0.328.6%
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News



iX Biopharma